FOXO1 and Hyperinsulinemia: EPA, but not the other n3-PUFAs, reduced hepatic FoxO1 which suggests greater inhibition of gluconeogenesis; however, this potential mechanism did not explain the improvements in fasting hyperinsulinemia, or the HOMA-IR score observed in the faEPA group.